Preprint Review Version 2 Preserved in Portico This version is not peer-reviewed

Metagenomics and Machine Learning-Based Precision Medicine Approaches for Autoimmune Diseases

These authors contributed equally to work.
Version 1 : Received: 9 April 2023 / Approved: 11 April 2023 / Online: 11 April 2023 (08:14:43 CEST)
Version 2 : Received: 21 April 2023 / Approved: 23 April 2023 / Online: 23 April 2023 (02:59:58 CEST)

How to cite: Zehrh, I.; Habiba, U.; Picco, M.R.; Bashir, S.H.; Rehman, U.A.; Haider, O.; Khoso, S. Metagenomics and Machine Learning-Based Precision Medicine Approaches for Autoimmune Diseases. Preprints 2023, 2023040209. https://doi.org/10.20944/preprints202304.0209.v2 Zehrh, I.; Habiba, U.; Picco, M.R.; Bashir, S.H.; Rehman, U.A.; Haider, O.; Khoso, S. Metagenomics and Machine Learning-Based Precision Medicine Approaches for Autoimmune Diseases. Preprints 2023, 2023040209. https://doi.org/10.20944/preprints202304.0209.v2

Abstract

The makeup of human microbiota has been linked to a number of autoimmune disorders. Recent developments in whole metagenome sequencing and 16S rRNA sequencing technology have considerably aided research into the microbiome and its relationship to disease. Due to the inherent high dimensionality and complexity of data generated by high-throughput platforms, conventional bioinformatics techniques could only provide an inadequate explanation for the most relevant changes and seldom provide correct predictions. Machine learning, on the other hand, is a subset of artificial intelligence applications that enable the untangling of high-dimensional systems and intricate knots in correlation by learning complex patterns and improving automatically from training data without being explicitly programmed. Machine learning is increasingly being utilized to research the influence of microbes on the onset of illness and other clinical features since computer power has increased dramatically in the last few decades. In this review paper, we focused on emerging methodological approaches of supervised machine learning algorithms for identification of autoimmune disorders utilizing metagenomics data, as well as the potential benefits and limitations of machine learning models in clinical applications.

Keywords

Gut microbiome; Machine learning; Deep learning; Metagenomics; Autoimmune diseases; Biomarkers discovery; Diagnostic models

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (1)

Comment 1
Received: 23 April 2023
Commenter: Shahzaib Khoso
Commenter's Conflict of Interests: Author
Comment: We added some more details about biomarker discovery and rephrase some sentences for simple explain procedures with correction of numbering of headings. Additionaly one authors name is corrected that were misspelled in last name previously.
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 1
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.